- Home
- LGVN vs SHPH Comparison
LGVN vs SHPH Comparison
Compare LGVN & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- SHPH
- Stock Information
- Founded
- LGVN 2014
- SHPH 2012
- Country
- LGVN United States
- SHPH United States
- Employees
- LGVN N/A
- SHPH N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- LGVN Health Care
- SHPH Health Care
- Exchange
- LGVN Nasdaq
- SHPH Nasdaq
- Market Cap
- LGVN 23.4M
- SHPH 2.3M
- IPO Year
- LGVN 2021
- SHPH 2022
- Fundamental
- Price
- LGVN $1.31
- SHPH $3.43
- Analyst Decision
- LGVN Strong Buy
- SHPH
- Analyst Count
- LGVN 3
- SHPH 0
- Target Price
- LGVN $8.67
- SHPH N/A
- AVG Volume (30 Days)
- LGVN 146.0K
- SHPH 188.8K
- Earning Date
- LGVN 08-13-2025
- SHPH 05-08-2025
- Dividend Yield
- LGVN N/A
- SHPH N/A
- EPS Growth
- LGVN N/A
- SHPH N/A
- EPS
- LGVN N/A
- SHPH N/A
- Revenue
- LGVN $2,225,000.00
- SHPH N/A
- Revenue This Year
- LGVN N/A
- SHPH N/A
- Revenue Next Year
- LGVN $51.48
- SHPH N/A
- P/E Ratio
- LGVN N/A
- SHPH N/A
- Revenue Growth
- LGVN 127.50
- SHPH N/A
- 52 Week Low
- LGVN $1.14
- SHPH $3.00
- 52 Week High
- LGVN $6.40
- SHPH $107.40
- Technical
- Relative Strength Index (RSI)
- LGVN 50.13
- SHPH 37.82
- Support Level
- LGVN $1.15
- SHPH $3.26
- Resistance Level
- LGVN $1.32
- SHPH $4.10
- Average True Range (ATR)
- LGVN 0.09
- SHPH 0.52
- MACD
- LGVN 0.01
- SHPH 0.04
- Stochastic Oscillator
- LGVN 45.31
- SHPH 15.08
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.